SMURF2 and nonpapillary renal cell carcinoma: Specifically, elevated mRNA levels of SMURF2 have been observed to correlate with improved outcomes in clear cell renal cell carcinoma (ccRCC), suggesting a protective function it serves by destabilizing HIF1α.